Article metrics

Efficacy and safety of the combined metabolic medication, containing inosine, nicotinamide, riboflavin and succinic acid, for the treatment of diabetic neuropathy: a multicenter randomized, double-blind, placebo-controlled parallel group clinical trial (CYLINDER)

 

Online download statistics by month:

Online download statistics by month: June 2022 to September 2024

AbstractFullPdf
Jun 202225652573143
Jul 20221138114465
Aug 202233033553
Sep 202218418142
Oct 202213814327
Nov 202215715331
Dec 202210910819
Jan 202314314225
Feb 202316416676
Mar 202310910234
Apr 2023939336
May 2023737330
Jul 2023968341
Aug 2023939331
Sep 202312612536
Oct 20231039720
Nov 2023797312
Dec 2023484722
Jan 2024635521
Feb 2024938541
Mar 2024696246
Apr 2024716734
May 2024918023
Jun 2024767335
Jul 2024846926
Aug 20241038734
Sep 2024989423
Total649664031026